{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:47:21Z","timestamp":1783529241673,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.compbiomed.2025.110314","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T02:39:21Z","timestamp":1746412761000},"page":"110314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"PB","title":["MASLD Risk Score (MRS) and Random Forest model (RF Model): Novel tools for screening and severity assessment of MASLD"],"prefix":"10.1016","volume":"192","author":[{"given":"Sanjaay","family":"Balakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmashree","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushiki S.","family":"Prabhudesai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4352-0172","authenticated-orcid":false,"given":"Ria","family":"Vijay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaykumar P.","family":"Gawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Kareenhalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.compbiomed.2025.110314_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110314_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110314_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110314_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110314_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110314_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110314_bib7","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1007\/s10620-015-3728-3","article-title":"Prevalence of nonalcoholic fatty liver disease and Economy","volume":"60","author":"Zhu","year":"2015","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110314_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: results of a prospective nationwide survey","volume":"32","author":"Cadranel","year":"2000","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110314_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110314_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hep.27844","article-title":"The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"Hepatology"},{"issue":"Nov","key":"10.1016\/j.compbiomed.2025.110314_bib11","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110314_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.compbiomed.2025.110314_bib13","author":"Bedogni"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110314_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110314_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110314_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"10.1016\/j.compbiomed.2025.110314_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.02.004","article-title":"A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models","volume":"110","author":"Christodoulou","year":"2019","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.compbiomed.2025.110314_bib18","first-page":"4766","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.compbiomed.2025.110314_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-08171-7_1","article-title":"Predicting disease risks using feature selection based on random forest and support vector machine","volume":"8492","author":"Yang","year":"2014","journal-title":"Lect. Notes Comput. Sci."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110314_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/bimj.200410133","article-title":"The Youden index and the optimal cut-point corrected for measurement error","volume":"47","author":"Perkins","year":"2005","journal-title":"Biom. J."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110314_bib21","first-page":"1","article-title":"Study of cardiovascular disease prediction model based on random forest in eastern China","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110314_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","article-title":"Non-invasive scores and serum biomarkers for fatty liver in the era of metabolic dysfunction-associated steatotic liver disease (MASLD): a comprehensive review from NAFLD to mafld and MASLD","volume":"13","author":"Abdelhameed","year":"2024","journal-title":"Curr Obes Rep"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110314_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1503\/cmaj.045232","article-title":"Nonalcoholic fatty liver disease","volume":"172","author":"Adams","year":"2005","journal-title":"CMAJ. Canadian Medical Association Journal"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110314_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02296-x","article-title":"Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study","volume":"18","author":"Ma","year":"2020","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110314_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.ijo.0803697","article-title":"Longitudinal changes in BMI and in an index estimating excess lipids among white and black adults in the United States","volume":"32","author":"Kahn","year":"2008","journal-title":"Int. J. Obes."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110314_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.metabol.2005.04.021","article-title":"Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake","volume":"54","author":"Farin","year":"2005","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110314_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11894-023-00883-8","article-title":"Screening, diagnosis, and staging of non-alcoholic fatty liver disease (NAFLD): application of society guidelines to clinical practice","volume":"25","author":"Ilagan-Ying","year":"2023","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110314_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MEG.0000000000000507","article-title":"Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"28","author":"Gong","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2025.110314_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/CLEP.S403314","article-title":"Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and meta-analysis","volume":"15","author":"Sun","year":"2023","journal-title":"Clin. Epidemiol."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110314_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113863","article-title":"The role of insulin resistance and diabetes in nonalcoholic fatty liver disease","volume":"21","author":"Fujii","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110314_bib31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12072-021-10242-2","article-title":"First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients","volume":"15","author":"Huang","year":"2021","journal-title":"Hepatol. Int."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110314_bib32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.compbiomed.2025.110314_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1207365","article-title":"Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110314_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.14172","article-title":"Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population","volume":"46","author":"Yip","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110314_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/SLA.0000000000002693","article-title":"Artificial intelligence in surgery: promises and perils","volume":"268","author":"Hashimoto","year":"2018","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110314_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110314_bib37","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41591-019-0548-6","article-title":"Do no harm: a roadmap for responsible machine learning for health care","volume":"25","author":"Wiens","year":"2019","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110314_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH \u2014 current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110314_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2337\/dsi23-0014","article-title":"Making sense of the nonalcoholic fatty liver disease clinical practice guidelines: what clinicians need to know","volume":"37","author":"Cusi","year":"2024","journal-title":"Diabetes Spectr."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525006651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525006651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:43:30Z","timestamp":1778564610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525006651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"alternative-id":["S0010482525006651"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110314","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MASLD Risk Score (MRS) and Random Forest model (RF Model): Novel tools for screening and severity assessment of MASLD","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110314"}}